{"id":58283,"date":"2023-10-24T01:02:17","date_gmt":"2023-10-23T23:02:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/"},"modified":"2023-10-24T01:02:17","modified_gmt":"2023-10-23T23:02:17","slug":"procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/","title":{"rendered":"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors"},"content":{"rendered":"
\n

\nExperienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board<\/i><\/p>\n

MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Procaps Group (NASDAQ: PROC) (\u201cProcaps\u201d or the \u201cCompany\u201d), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the appointment of one new member to its Board of Directors (the \u201cBoard\u201d).<\/p>\n

<\/a>
<\/a><\/p>\n

\nOn October 23, 2023, the Board appointed Sandra S\u00e1nchez y Oldenhage as a Director to fill the current vacancy on the Board, effective immediately and for a period ending at its annual general meeting of shareholders for the fiscal year ended December 31, 2023.<\/p>\n

\nSandra S\u00e1nchez y Oldenhage has over 35 years\u2019 experience in steering mature, start-up, and turn-around\/restructuring enterprises toward tangible, sustainable growth within diverse international markets. She currently serves as president and chief executive officer of PharmAdvice, a consulting firm offering pharmaceutical, medical device and biotech guidance to healthcare companies entering or operating in Mexico. Previously, she oversaw oncology operations for the North LatAm region at Novartis during 2019 and 2020. She also currently serves as a director on the board of directors of Fenix Holding and Farmapiel, specifically holding the title of chair of the nominations, compensation, and governance committee at Fenix Holding, in addition to serving as a regional board member of Grupo Financiero Banorte. Moreover, she is the former chair of the Pharma Industry Trade Association (AMIIF) in Mexico. Ms. S\u00e1nchez y Oldenhage previously worked at several of the world\u2019s leading pharmaceutical companies, including as president of Biogen\u2019s Mexico affiliate, general manager, and country president for Amgen Inc., and as CEO of Probiomed. She received a bachelor\u2019s degree in business administration at Universidad Intercontinental in Mexico City, Mexico.<\/p>\n

\n\u201cWith her vast operational experience across numerous pharmaceutical and biotechnology companies, in addition to her nuanced understanding of Mexican and LatAm healthcare markets and her prior board experience, Sandra is an excellent addition to our Board. We look forward to working with her to help propel Procaps into its next phase of growth as we advance product development and market expansion,\u201d said Ruben Minski, Chairman of the Board and CEO of Procaps Group.<\/p>\n

\nAbout Procaps Group<\/b><\/p>\n

\nProcaps Group, S.A. (\u201cProcaps\u201d) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,500 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products, prescription pharmaceutical drugs (Rx), nutritional supplements, and high-potency clinical solutions.<\/p>\n

\nFor more information, visit www.procapsgroup.com<\/a> or Procaps\u2019 investor relations website investor.procapsgroup.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Melissa Angelini
\n
ir@procapsgroup.com<\/a>
investor.procapsgroup.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Procaps Group (NASDAQ: PROC) (\u201cProcaps\u201d or the \u201cCompany\u201d), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the appointment of one new member to its Board of Directors (the \u201cBoard\u201d). On October 23, 2023, the Board appointed … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58283","6":"format-standard","7":"category-industry"},"yoast_head":"\nProcaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Procaps Group (NASDAQ: PROC) (\u201cProcaps\u201d or the \u201cCompany\u201d), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the appointment of one new member to its Board of Directors (the \u201cBoard\u201d). On October 23, 2023, the Board appointed ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-23T23:02:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231023959061\/en\/1903496\/21\/Procaps_Group_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors\",\"datePublished\":\"2023-10-23T23:02:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/\"},\"wordCount\":453,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231023959061\\\/en\\\/1903496\\\/21\\\/Procaps_Group_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/\",\"name\":\"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231023959061\\\/en\\\/1903496\\\/21\\\/Procaps_Group_Logo.jpg\",\"datePublished\":\"2023-10-23T23:02:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231023959061\\\/en\\\/1903496\\\/21\\\/Procaps_Group_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231023959061\\\/en\\\/1903496\\\/21\\\/Procaps_Group_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors - Pharma Trend","og_description":"Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Procaps Group (NASDAQ: PROC) (\u201cProcaps\u201d or the \u201cCompany\u201d), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the appointment of one new member to its Board of Directors (the \u201cBoard\u201d). On October 23, 2023, the Board appointed ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/","og_site_name":"Pharma Trend","article_published_time":"2023-10-23T23:02:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231023959061\/en\/1903496\/21\/Procaps_Group_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors","datePublished":"2023-10-23T23:02:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/"},"wordCount":453,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231023959061\/en\/1903496\/21\/Procaps_Group_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/","url":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/","name":"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231023959061\/en\/1903496\/21\/Procaps_Group_Logo.jpg","datePublished":"2023-10-23T23:02:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231023959061\/en\/1903496\/21\/Procaps_Group_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231023959061\/en\/1903496\/21\/Procaps_Group_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/procaps-appoints-sandra-sanchez-y-oldenhage-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Procaps Appoints Sandra S\u00e1nchez y Oldenhage to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58283"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58283\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}